Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2014

01-06-2014 | Guideline

Preface: evidence-based clinical practice guidelines for CKD—an abridged English version

Author: Kenjiro Kimura

Published in: Clinical and Experimental Nephrology | Issue 3/2014

Login to get access

Excerpt

The concept of chronic kidney disease (CKD), first proposed in 2002 in the United States, has now become accepted around the world. CKD is a risk factor not only for progression to end-stage kidney disease but also for the onset or progression of cardiovascular diseases. As a result, early detection and treatment of CKD are now being prioritized as urgent concerns. The Japanese Society of Nephrology (JSN) has long been focused on CKD, and in September 2007, we published the “Clinical Practice Guidebook for the Diagnosis and Treatment of CKD” (Guidebook for CKD) (Chairperson: Yasuhiko Iino) for non-specialists. Subsequently, in March 2009, the JSN published the “Evidence-Based Clinical Practice Guidelines for CKD 2009” (Guidelines for CKD 2009) (Chairperson: Sei Sasaki) for kidney specialists. The difference between these two publications is that the Guidebook for CKD was based on a general consensus of the committee, whereas the Guidelines for CKD 2009 was based on the rigorous evaluation of clinical evidence. …
Metadata
Title
Preface: evidence-based clinical practice guidelines for CKD—an abridged English version
Author
Kenjiro Kimura
Publication date
01-06-2014
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 3/2014
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-014-0948-3

Other articles of this Issue 3/2014

Clinical and Experimental Nephrology 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.